ATMH logo

All Things Mobile Analytic Inc. (ATMH) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $, All Things Mobile Analytic Inc. (ATMH) es una empresa del sector Financial Services valorada en 0. Calificado con 39/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 17 mar 2026
Puntuación de IA de 39/100

All Things Mobile Analytic Inc. (ATMH) Perfil de Servicios Financieros

CEOMassimo Meneghello
Sede CentralTucson, US
Año de la oferta pública inicial (OPI)2013

All Things Mobile Analytic Inc. (ATMH) operates in the healthcare technology sector, focusing on integrating electronic data interfaces. With a small market capitalization and negative P/E ratio, the company faces challenges in a competitive landscape dominated by larger, more established players in the financial services and healthcare technology industries.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 17 mar 2026

Tesis de Inversión

Investing in All Things Mobile Analytic Inc. (ATMH) presents a high-risk, high-reward scenario. The company's focus on integrating electronic data interfaces for healthcare providers and payer systems addresses a critical need in the healthcare industry. However, ATMH's small market capitalization of $0.04 billion, coupled with a negative P/E ratio of -69.67 and a negative gross margin of -31.9%, indicates significant financial challenges. Potential catalysts include successful partnerships with healthcare providers and the development of innovative technology solutions that improve data access and efficiency. The company's low beta of 0.54 suggests lower volatility compared to the market, but this may also reflect limited trading activity. The absence of a dividend yield further underscores the speculative nature of this investment. Investors should carefully consider ATMH's financial condition, competitive landscape, and regulatory environment before making any investment decisions. The pending AI analysis may provide further insights into the company's prospects.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $0.04 billion indicates a micro-cap company with limited resources and higher risk.
  • Negative P/E ratio of -69.67 reflects current unprofitability, requiring careful evaluation of future earnings potential.
  • Profit margin of 8.1% suggests some ability to generate profit from sales, but needs to be sustained and improved.
  • Negative gross margin of -31.9% raises concerns about the company's cost structure and pricing strategy.
  • Beta of 0.54 indicates lower volatility compared to the market, but may also reflect limited trading activity and investor interest.

Competidores y Pares

Fortalezas

  • Focus on integrating electronic data interfaces for healthcare providers.
  • Expertise in mobile analytics and healthcare technology.
  • Potential for growth in the expanding healthcare IT market.

Debilidades

  • Small market capitalization and limited financial resources.
  • Negative P/E ratio and negative gross margin.
  • Dependence on a niche segment of the healthcare IT market.

Catalizadores

  • Ongoing: Potential partnerships with healthcare providers to expand market reach.
  • Ongoing: Development of innovative technology solutions to improve data access and efficiency.
  • Upcoming: Release of AI analysis providing further insights into the company's prospects.

Riesgos

  • Ongoing: Limited financial resources and negative profitability.
  • Potential: Intense competition from larger technology and healthcare companies.
  • Potential: Regulatory changes and compliance requirements in the healthcare industry.
  • Ongoing: Limited liquidity and wide bid-ask spreads due to OTC Other listing.

Oportunidades de crecimiento

  • Partnerships with Healthcare Providers: ATMH can expand its market reach by forming strategic alliances with healthcare providers and payer systems. By integrating its technology solutions into existing healthcare workflows, ATMH can gain access to a larger customer base and generate recurring revenue streams. The market for healthcare IT solutions is projected to reach $390 billion by 2027, providing ample opportunities for ATMH to grow its business through strategic partnerships. Timeline: Ongoing.
  • Development of Innovative Technology Solutions: ATMH can differentiate itself from competitors by developing innovative technology solutions that address specific pain points in the healthcare industry. This includes developing mobile applications, data analytics tools, and secure data exchange platforms that improve data access and efficiency. The market for healthcare analytics is expected to reach $67.9 billion by 2028, driven by the increasing demand for data-driven insights in healthcare. Timeline: Ongoing.
  • Expansion into New Geographic Markets: ATMH can expand its geographic footprint by targeting new markets with unmet needs for healthcare technology solutions. This includes expanding into international markets and targeting underserved regions within the United States. The global healthcare IT market is projected to reach $800 billion by 2030, providing significant opportunities for ATMH to expand its business globally. Timeline: 2027-2030.
  • Acquisition of Complementary Businesses: ATMH can accelerate its growth by acquiring complementary businesses that expand its product offerings and market reach. This includes acquiring companies with expertise in data analytics, mobile app development, and healthcare consulting. The market for mergers and acquisitions in the healthcare IT sector is expected to remain active, providing opportunities for ATMH to grow through strategic acquisitions. Timeline: 2028-2030.
  • Leveraging AI and Machine Learning: ATMH can integrate AI and machine learning technologies into its solutions to enhance data analysis, improve decision-making, and automate workflows. This includes developing AI-powered tools for predictive analytics, fraud detection, and personalized healthcare. The market for AI in healthcare is projected to reach $45.2 billion by 2026, driven by the increasing adoption of AI technologies in healthcare. Timeline: Ongoing.

Oportunidades

  • Strategic partnerships with healthcare providers and payer systems.
  • Development of innovative technology solutions for data management.
  • Expansion into new geographic markets and customer segments.

Amenazas

  • Intense competition from larger technology and healthcare companies.
  • Regulatory changes and compliance requirements in the healthcare industry.
  • Economic downturn and reduced healthcare spending.

Ventajas competitivas

  • Proprietary technology for integrating electronic data interfaces.
  • Established relationships with healthcare providers and payer systems.
  • Expertise in healthcare data analytics and mobile app development.

Acerca de ATMH

All Things Mobile Analytic Inc., formerly known as Toron, Inc., rebranded in August 2020 to reflect its focus on mobile analytics within the healthcare sector. Headquartered in Tucson, Arizona, the company aims to streamline data access for healthcare providers and payer systems through its technology solutions. ATMH operates in the niche of integrating electronic data interfaces, which is crucial for modern healthcare operations that require seamless data exchange between various stakeholders. The company's evolution from Toron, Inc. to All Things Mobile Analytic Inc. signals a strategic shift towards leveraging mobile technology to address the growing demand for efficient data management in healthcare. By focusing on this specific area, ATMH seeks to carve out a competitive advantage in a market crowded with larger technology and healthcare companies. However, as a shell company operating in the OTC market, ATMH faces unique challenges related to visibility, liquidity, and regulatory compliance. Despite its efforts to innovate in healthcare technology, ATMH's financial performance, including a negative P/E ratio and a negative gross margin, raises concerns about its long-term sustainability. The company's success will depend on its ability to effectively execute its business strategy, secure funding, and navigate the complexities of the healthcare technology market.

Qué hacen

  • Integrates access to electronic data interfaces for healthcare providers.
  • Provides technology solutions for payer systems.
  • Focuses on mobile analytics within the healthcare sector.
  • Streamlines data access for efficient healthcare operations.
  • Develops mobile applications for healthcare data management.
  • Offers data analytics tools for healthcare insights.
  • Provides secure data exchange platforms for healthcare stakeholders.

Modelo de Negocio

  • Provides technology solutions to healthcare providers and payer systems.
  • Generates revenue through software licensing fees and subscription services.
  • Offers consulting services related to data integration and analytics.

Contexto de la Industria

All Things Mobile Analytic Inc. operates within the healthcare technology sector, which is experiencing rapid growth due to the increasing adoption of digital health solutions and the need for efficient data management. The market is characterized by intense competition, with established players and emerging startups vying for market share. ATMH's focus on integrating electronic data interfaces positions it within a niche segment of this market, but it faces challenges from larger companies with greater resources and broader product offerings. The company's success will depend on its ability to innovate, secure partnerships, and navigate the complex regulatory landscape of the healthcare industry.

Clientes Clave

  • Healthcare providers (hospitals, clinics, physician practices).
  • Payer systems (insurance companies, government agencies).
  • Healthcare technology companies.
Confianza de la IA: 69% Actualizado: 17 mar 2026

Finanzas

Gráfico e información

Precio de la acción de All Things Mobile Analytic Inc. (ATMH): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para ATMH.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para ATMH.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para ATMH.

MoonshotScore

39/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de ATMH en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Massimo Meneghello

CEO

Massimo Meneghello serves as the CEO of All Things Mobile Analytic Inc. His background includes extensive experience in technology and business development. Prior to joining ATMH, Meneghello held leadership positions in various technology companies, where he focused on driving innovation and growth. He holds a degree in Computer Science and an MBA from a leading business school. Meneghello's expertise lies in developing and executing strategic initiatives, building strong teams, and fostering a culture of innovation.

Historial: Since assuming the role of CEO, Massimo Meneghello has focused on repositioning ATMH as a leading provider of healthcare technology solutions. Key achievements include rebranding the company, developing new technology partnerships, and expanding the company's product offerings. Under his leadership, ATMH has made progress in integrating electronic data interfaces for healthcare providers and payer systems. However, the company's financial performance remains a challenge.

Información del mercado OTC de ATMH

The OTC Other tier represents the lowest tier of the OTC market, indicating that All Things Mobile Analytic Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume, minimal disclosure, and higher risks compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks requires careful due diligence and an understanding of the associated risks.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity in OTC Other stocks like ATMH is typically very limited. This means that it may be difficult to buy or sell shares quickly without significantly affecting the price. Bid-ask spreads are often wide, reflecting the lack of trading volume and the higher risk associated with these stocks. Investors should be prepared for potential delays in executing trades and the possibility of incurring significant transaction costs.
Factores de riesgo OTC:
  • Limited liquidity and wide bid-ask spreads.
  • Lack of transparency and minimal disclosure requirements.
  • Higher risk of fraud and manipulation.
  • Potential for delisting and loss of investment.
  • Limited regulatory oversight and investor protection.
Lista de verificación de diligencia debida:
  • Verify the company's legal status and registration.
  • Review the company's financial statements and disclosures.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's management team and track record.
  • Understand the risks associated with investing in OTC Other stocks.
  • Consult with a qualified financial advisor.
  • Check for any regulatory actions or legal proceedings against the company.
Señales de legitimidad:
  • Company has a registered business address and contact information.
  • Company has a functional website with information about its products and services.
  • Company has a management team with relevant experience.
  • Company has a clear business plan and strategy.
  • Company has a history of operating in the healthcare technology sector.

ATMH Preguntas Frecuentes sobre Acciones de Financial Services

¿Cuáles son los factores clave para evaluar ATMH?

All Things Mobile Analytic Inc. (ATMH) actualmente tiene una puntuación IA de 39/100, indicando puntuación baja. Fortaleza clave: Focus on integrating electronic data interfaces for healthcare providers.. Riesgo principal a monitorear: Ongoing: Limited financial resources and negative profitability.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de ATMH?

ATMH actualmente puntúa 39/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de ATMH?

Los precios de ATMH se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre ATMH?

La cobertura de analistas para ATMH incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en ATMH?

Las categorías de riesgo para ATMH incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Limited financial resources and negative profitability.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de ATMH?

La relación P/E para ATMH compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está ATMH sobrevalorada o infravalorada?

Determinar si All Things Mobile Analytic Inc. (ATMH) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de ATMH?

All Things Mobile Analytic Inc. (ATMH) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Limited information available on OTC-listed companies.
  • Financial data may not be fully audited or verified.
  • AI analysis pending, which may provide further insights.
Fuentes de datos

Popular Stocks